Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS)
Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
At close: 03:00PM CST
Currency in CNY
Valuation Measures4
| Market Cap (intraday) | 8.88B |
| Enterprise Value | 6.30B |
| Trailing P/E | 38.00 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.10 |
| Price/Book (mrq) | 2.18 |
| Enterprise Value/Revenue | 0.96 |
| Enterprise Value/EBITDA | 20.11 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | -22.93% |
| S&P500 52-Week Change 3 | 26.27% |
| 52 Week High 3 | 11.75 |
| 52 Week Low 3 | 6.38 |
| 50-Day Moving Average 3 | 8.59 |
| 200-Day Moving Average 3 | 9.09 |
Share Statistics
| Avg Vol (3 month) 3 | 11.98M |
| Avg Vol (10 day) 3 | 26.64M |
| Shares Outstanding 5 | 1.02B |
| Implied Shares Outstanding 6 | 1.02B |
| Float 8 | 438.74M |
| % Held by Insiders 1 | 55.89% |
| % Held by Institutions 1 | 4.91% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.10 |
| Trailing Annual Dividend Yield 3 | 1.14% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Aug 17, 2022 |
| Last Split Factor 2 | 12.5:10 |
| Last Split Date 3 | Feb 20, 2006 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 5.55% |
| Operating Margin (ttm) | 6.77% |
Management Effectiveness
| Return on Assets (ttm) | 1.24% |
| Return on Equity (ttm) | 6.13% |
Income Statement
| Revenue (ttm) | 4.2B |
| Revenue Per Share (ttm) | 4.16 |
| Quarterly Revenue Growth (yoy) | -30.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 319.99M |
| Net Income Avi to Common (ttm) | 233.09M |
| Diluted EPS (ttm) | 0.23 |
| Quarterly Earnings Growth (yoy) | -54.40% |
Balance Sheet
| Total Cash (mrq) | 3.24B |
| Total Cash Per Share (mrq) | 3.29 |
| Total Debt (mrq) | 661.31M |
| Total Debt/Equity (mrq) | 13.91% |
| Current Ratio (mrq) | 3.02 |
| Book Value Per Share (mrq) | 4.14 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 417.57M |
| Levered Free Cash Flow (ttm) | 3.87B |
© 2024 Yahoo. All rights reserved.